(Q39890156)

15 September 2017

Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis (English)

1 reference

15 September 2017

0 references

0 references

0 references

Jonathan McCormick

1

1 reference

15 September 2017

Gita Mehta

2

1 reference

15 September 2017

Hanne V Olesen

3

1 reference

15 September 2017

Laura Viviani

4

1 reference

15 September 2017

Milan Macek

5

1 reference

15 September 2017

Anil Mehta

6

1 reference

15 September 2017

European Registry Working Group

7

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

15 September 2017

1 reference

15 September 2017

375

1 reference

15 September 2017

9719

1 reference

15 September 2017

1007-1013

1 reference

The changing epidemiology of cystic fibrosis

15 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962161-9

7 January 2021

Determinants of mortality from cystic fibrosis in Canada, 1970-1989.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962161-9

7 January 2021

CFTR Genotype as a Predictor of Prognosis in Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962161-9

7 January 2021

The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962161-9

7 January 2021

Median household income and mortality rate in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962161-9

7 January 2021

Cystic fibrosis mortality trends in France.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962161-9

7 January 2021

Newborn screening for cystic fibrosis is associated with reduced treatment intensity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962161-9

7 January 2021

Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962161-9

7 January 2021

Economic implications of newborn screening for cystic fibrosis: a cost of illness retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962161-9

7 January 2021

Comparative analysis of Cystic Fibrosis Registry data from the UK with USA, France and Australasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962161-9

7 January 2021

Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962161-9

7 January 2021

Cystic fibrosis mortality and survival in the UK: 1947-2003

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962161-9

7 January 2021

International practice patterns by age and severity of lung disease in cystic fibrosis: data from the Epidemiologic Registry of Cystic Fibrosis (ERCF).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962161-9

7 January 2021

Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962161-9

7 January 2021

The prevalence of cystic fibrosis in the European Union

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962161-9

7 January 2021

International comparison of median age at death from cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962161-9

7 January 2021

10.1016/S0140-6736(09)62161-9

Identifiers

DOI

1 reference

15 September 2017

1 reference